Phase IIB Randomized, Placebo Controlled Trial of Pioglitazone for Oral Premalignant Lesions An Inter-Consortium Collaborative Study.
Phase of Trial: Phase II
Latest Information Update: 12 Apr 2016
At a glance
- Drugs Pioglitazone (Primary)
- Indications Orofacial cancer
- Focus Therapeutic Use
- 29 Mar 2016 Primary endpoint has been amended as per ClinicalTrials.gov.
- 29 Mar 2016 According to ClinicalTrials.gov Status changed from completed to discontinued due to slow accrual.
- 04 Sep 2013 Additional lead trial center added as reported by European Clinical Trials Database.